idamayag.bsky.social
@idamayag.bsky.social
Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab

✅ Just Accepted
🔗 https://bit.ly/4qUWJmi
November 13, 2025 at 11:40 PM
who.int WHO @who.int · Nov 12
Tuberculosis (TB) that doesn’t respond to standard drugs is called drug-resistant TB and emerges when TB medicines are used inappropriately.

Although the number of people developing drug-resistant TB has declined since 2015, it remains a global public health crisis affecting 390 000 people in 2024.
November 13, 2025 at 11:40 PM
The IDSA now considers infections beyond the bladder as complicated UTIs, regardless of gender. 🏥 See IDSA's infographic on uUTI vs cUTI classifications.
November 13, 2025 at 11:39 PM
Response to Cardiac Complications of Mycoplasma pneumoniae: Overlooked Confounders, Biomarkers, and Host-Driven Shifts

✅ Just Accepted
🔗 https://bit.ly/3JZgbxB
November 13, 2025 at 11:38 PM
Cross-reactivity of beta-lactams. A review of the beta-lactam cross-reactivity patterns based on key pharmacological structures and known clinical cross-reactivity #idsky
November 7, 2025 at 1:38 AM
Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis?

✅ Just Accepted
🔗 https://bit.ly/3JNCW7x
November 7, 2025 at 1:37 AM
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4og9whx
October 28, 2025 at 9:52 PM
Community-acquired pneumonia is the leading infectious cause of morbidity and mortality globally.

Yet, there are several challenges associated with diagnosis, treatment, and long-term management of Community-acquired pneumonia.

Find out more in a new Seminar: tinyurl.com/hd2fwz7n
October 21, 2025 at 6:19 PM
A randomized phase 1 study investigating gut microbiome changes with moxifloxacin vs. oral vancomycin: Implications for Clostridioides difficile risk

✅ Just Accepted
#IDSky
🔗 https://bit.ly/47g3wy5
October 21, 2025 at 6:19 PM
Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3W4CLr3
October 16, 2025 at 10:43 PM
Prevalence of candidate vaccine targets and genomic features of pediatric invasive Streptococcus agalactiae in Japan

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4n3jpNU
October 16, 2025 at 10:42 PM
The number of deaths caused by antimicrobial resistance is predicted to rise from 1 millio to 2 million death per year by 2050. Reasons:
- Too few new drugs
- Excessive use of antibiotics in agriculture
- Antibiotics overuse in medical practice
- Lack of awareness
www.nature.com/articles/d41...
The rise of ‘nightmare bacteria’: antimicrobial resistance in six charts
Data reveal how the global challenge to reduce deaths and infections from drug-resistant bacteria is not going according to plan.
www.nature.com
October 9, 2025 at 4:29 PM
Blood cultures contain populations of genetically diverse Candida albicans strains that may differ in echinocandin tolerance and fitness

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Wk7W1y
October 2, 2025 at 1:51 AM
Randomized pragmatic trial of the comparative effectiveness of chicken egg-based inactivated, mammalian cell-culture-based inactivated, and recombinant protein quadrivalent seasonal influenza vaccines in US Military Health System

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pOOFmG
September 24, 2025 at 12:27 AM
Before the HBV vaccine was introduced as part of childhood immunization in Cameroon it wasn't uncommon to see very young people with liver cancer secondary to chronic hepatitis B. The youngest case I saw was a 17yo boy with liver cancer 2/2 to perinatally acquired HBV
www.nbcnews.com/health/kids-...
The hepatitis B vaccine has sharply cut infections in children. Why are some against it?
The CDC's vaccine advisory panel is set to discuss and possibly vote on the vaccine at a meeting next week.
www.nbcnews.com
September 11, 2025 at 3:54 PM
September 4, 2025 at 12:01 AM
Tetracyclines, esp doxycycline and minocycline, are of interest because of their broad-spectrum activities,good oral bioavailability, and potential efficacy in treating BJIs
🆕💫Review Oral tetracyclines for bone and joint infections: what do we know? #idsky
jbji.copernicus.org/articles/10/...
Oral tetracyclines for bone and joint infections: what do we know?
Abstract. Background and aim: Complex bone and joint infections (BJIs), including prosthetic joint infections (PJIs) and infections associated with osteosynthetic materials, present significant treatm...
jbji.copernicus.org
April 25, 2025 at 7:03 PM